Professional Documents
Culture Documents
1. 病毒會引起各種不同的病
2. 病毒是研究基因最好的對象
3. 病毒學是免疫學的始祖
4. 病毒可以作為基因治療的載體
Virus has many forms and shapes
Morphology of viruses
Icosahedral
Helical
病 毒 的 形 狀
蛋白質
脂肪膜
Quasisymmetry principle of icosahedral
structure
pentamer
hexamer
Virion structure
• Icosahedra
• Quasi-equivalent principle
• Triangulation numbers
– Capsomers C=10 x (T-1) + 12
– T=h2+hk+k2
• dsDNA
• ssDNA
• dsRNA
• ssRNA (+)
• ssRNA (-)
• ssRNA DNA
The Central Dogma
RNA
One-step growth curve
Transcription
Translation macromolecular synthesis
Replication
Virion assembly
Maturation Exit
Release
• Virus entry:
– Tropism: Susceptibility and permissivity
– Cellular receptors: tissue specificity
• Receptor-mediated endocytosis
– pH-dependent (acidic pH)
Replication and
transcription of DNA viruses
mRNAs transcription
α-amanitin-sensitive
Replication
Replication and transcription of RNA
viruses
Replication (+) (+) (–) (–)
Actinomycin D-resistant
(–) (–)(+) (–)
α-amanitin-resistant
Cycloheximide-sensitive or resistant
Asymmetrical synthesis
mRNAs
(–) (+)
Replicative intermediate (RI) RNA
(-)(+) 3’5’
5’ 5’ 5’
RNase
5’
RF RI RF
(Replicative form)
RNA-dependent RNA polymerase (RdRP)
GDD motif
Right-handed “palm-thumb-fingers”
Share sequence and structure with other polymerases
No proof-reading activity
“quasispecies”
High mutation frequencies
Primer-dependent or –independent (de novo synthesis)
Transcriptional cascades
early and late: divided by DNA replication
• Burst
• Mature on the plasma membrane
• Mature on the ER or Golgi
Genetics of virus infection
• Mutations
• Recombination
• Complementation
• Pseudotype virus particles
Viral infection of whole animals
• Viral portal of entry (skin, respiratory tract, GI, etc)
• Regional lymph nodes
• Target organs.
Host defense
– Adaptive immunity
• Antibody, cell-mediated immunity
• MHC functions and expression
Mechanisms of viral escape from host’s
defense
• Virokines
• Viroceptors
• Blocking of adaptive immunity: e.g.,
interference of MHC expression or
functions; production of decoy cytokine
receptors
• Blocking of innate immunity, e.g. interferon
• Blocking or inducing apoptosis
• Antigenic variations
Cell Res. 16, 141-147 (2006) Feb
Interferon
induction
FADD Adapter
Caspase8, 10 TANK ?
NAP-1
J. Immunol. 176,
4520 (2006) Apr.
Acute infection
(SARS)
Persistent infection
(LCMV)
Latent, reactivating
infection (HSV)
N (Neuraminidase)
H (Hemaggutinin)
PB1
PB2
PA
HA
NP
NA
Lipid bilayer
NS
M
RNA M1
8
M2 (Ion channel)
4 5 6 7
1 2 3
PB1
PB2 Transcriptase
PA complex
NP
NS2
Influenza virus proteins
Hemagglutinin (H):
Binds to cellular receptor (Determines the
host species)
The major viral antigen
Induces protective antibody
Neuraminidase (N):
Helps virus spread through the body
Induces semiprotective antibodies
Other proteins (e.g. PB2 1997 avian flu):
Viral replication
NS1 inhibits interferon ptroduction
Sialic acid as the receptor for influenza
viruses
1
2
“poison” 3 “poison”
H1 H1
4 H5 Anti-avian H5 Ab
5
6
7
8
• RNA reassortment
– Simultaneious infection of two virus
strains (Antigenic Shift), acquiring the
human H protein
• Accumulation of RNA mutations to make
an avian H protein (I.e. H5N1) capable of
infecting human cells
How can an avian virus
mutate into a human virus?
• May need more than 25 mutations?
H: 1 or 2 amino acids
PA: 4 or 5 amino acids?
PB1: 1 amino acid?
PB2: 2 amino acids?
anti-flu drugs
• Anti-Neuraminidase. Relenza
(Zanamivir) and Tamiflu
(Osteltamivir)
The predominant Influenza virus
strains
(trivalent vaccine)
B
H3N2
H1N2
H2N2
A
H5N1
H1N1 H1N1
1918 40 50 60 70 80 90 2000
Viral virulence of influenza virus
• Hemagglutinin
• Neuraminidase
• PB1 (?)
• NS1 (?)